(Reuters) - Life-sciences and health investing, long shunned by venture-capital investors, is making a comeback.

Several venture firms globally have each raised or are raising funds this year in the $200 million to $400 million range dedicated to life sciences, biotech and medicine, while others have raised large, diversified funds with big chunks dedicated to those fields.

Venture capitalists are taking that money and pushing it into several life-sciences and health-related fields. Last year, venture backers invested $4.82 billion in biotechnology, up 24 percent from 2010. Medical-devices venture investment rose 17 percent last year, and healthcare services rose 41 percent.

http://www.reuters.com/article/2012/09/24/us-venture-capital-life-sciences-idUSBRE88N0EK20120924